Rapport Therapeutics Inc

Research Rapport Therapeutics Inc (RAPP) on Bullrun: market cap USD 1.93B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerRAPP
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.93B
• Financial periodFY2025
• Net income-USD 111.48M
• Free cash flow-USD 88.09M

Valuation Snapshot

latest market cap is USD 1.93B.

About Rapport Therapeutics Inc

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.

Frequently asked questions

What is Rapport Therapeutics Inc's market cap?

Rapport Therapeutics Inc's market capitalization is USD 1.93B.

What does Rapport Therapeutics Inc do?

Rapport Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company that focuses on the discovery and development of transformational small molecule medicines for patients suffering from central nervous system (CNS) disorders.